Ausgabe 4/2013
Inhalt (6 Artikel)
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
Muriel Noetzli, Chin B. Eap
Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment
Jochen Graff, Sebastian Harder
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib
Mary Phelan, Judith Anzures-Cabrera, David J. Carlile, Lucy Rowell, Olaf Kuhlmann, Gerhard Arold, Richard Robson, Darren Bentley
Population Pharmacokinetics of Tranexamic Acid in Paediatric Patients Undergoing Craniosynostosis Surgery
Susan M. Goobie, Petra M. Meier, Navil F. Sethna, Sulpicio G. Soriano, David Zurakowski, Snehal Samant, Luis M. Pereira
Ciclosporin Population Pharmacokinetics and Bayesian Estimation in Thoracic Transplant Recipients
Dorothée Fruit, Annick Rousseau, Catherine Amrein, Florence Rollé, Nassim Kamar, Laurent Sebbag, Michel Redonnet, Eric Epailly, Pierre Marquet, Aurélie Prémaud
Population Pharmacokinetics of Tobramycin in Patients With and Without Cystic Fibrosis
Stefanie Hennig, Joseph F. Standing, Christine E. Staatz, Alison H. Thomson